Medplus Health Services Ltd

Q1 FY27Retailing

Medplus Health Services Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹656

Market cap₹7.9K Cr

P/E37.7

Updated23 Sept 2026

Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueGood growth

MarginMargins steady

CapexNo capex planned

The short version

MedPlus aims for a Same Store Sales Growth (SSSG) target of around 9%-10% for the full year FY27, though the Q1 reported SSSG was 15%. The company aims for a same-store sales growth (SSSG) target of around 9-10% for the full year FY27, with quarter 1 showing a strong 15% SSSG.

From Medplus Health Services Ltd's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

Good growth

MedPlus aims for a Same Store Sales Growth (SSSG) target of around 9%-10% for the full year FY27, though the Q1 reported SSSG was 15%. (page 19)
Company expects volume growth driven by new store openings and better performance of existing stores. (page 19)
Franchise store additions remain on track with guidance of 800 net store openings for FY27. (page 13)
Revenue growth is expected to remain strong, with quarterly growth of 22% observed recently. (page 17)
Management emphasizes stabilizing and increasing private label share, contributing to margin improvement and revenue recovery. (page 19)
The company remains focused on contiguous state expansion rather than rapid pan-India expansion for the core pharmacy business. (page 17)

2 more points management made on revenue & sales performance

Profitability & Margins

The company aims for a same-store sales growth (SSSG) target of around 9-10% for the full year FY27, with quarter 1 showing a strong 15% SSSG.
Management is focused on recovering a 100 basis point decline in gross margins due to reduced private label share, expecting incremental quarterly private label growth of 0.25%-0.3% to offset this.
EBITDA margins are targeted to return to earlier levels (around 9%), with ongoing cost management including discount structure adjustments effective July 7, 2026.
Q1 operating EBITDA was INR651 million (3.5%), with confidence that efforts will close gaps in upcoming quarters.
The company is cautious and recommends waiting for Q2 data before providing updated full-year EBITDA or earnings guidance.

2 more points management made on profitability & margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

No capex planned

The company had approved capex plans including INR40 crores for a food park and oil extraction unit and another for a wellness services facility.
These capex proposals have now been put on hold as of July 2026 after further deliberation and market feedback.
Management emphasized that capex on the core business—warehousing and stores—has not stopped and will continue.
The pause is temporary and does not indicate a permanent halt on capex spending; core business investments will continue.
Wellness and concierge medicine-related expansion plans, initially considered, are unlikely to proceed for the moment.

2 more points management made on capital expenditure plans

Top-ranked in Retailing

Ranked on what management guided this quarter

5x potential

1V2 Retail₹7.8K Cr

Rev 1Mar 3

2Entero Healthcar₹7.5K Cr

Rev 2Mar 2

3₹688 Cr

Rev 2Mar 2

4₹3.2L Cr

Rev 2Mar 3

5₹1.2L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

No explicit mention of any new fundraising through debt or equity in the current calls or presentations.
Promoters' debt stands at around INR 1,150 crores (including interest), but decisions related to promoter debt are managed by the family office and are separate from the listed company.
The company currently has a debt-free balance sheet with over INR 600 crores in cash.
They are evaluating options for utilizing cash, including potential dividend increases or share buybacks, but no concrete plans announced.

2 more points management made on fundraising & capital structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript of MedPlus Health Services Limited's Q1 FY27 earnings call dated July 22, 2026, does not explicitly mention any details regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Store network expansions and conversions. - Revenue growth, gross margin fluctuations, and private label performance. - Operational metrics and financial results including EBITDA and margins. - Capital expenditure plans and their temporary hold. - Impact of labor cost increases and pricing/discount adjustments.

2 more points management made on order book & pipeline

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Medplus Health Services Ltd's management said in earlier quarters

Others in Retailing this season

Shiprocket Ltd (Q1 FY27)
Core business shipments have grown by 31%, with revenue growing at 22%, indicating healthy volume-driven growth. Key concall takeaways from Shiprocket Ltd's Q1…
Vishal Mega Mart Ltd (Q1 FY27)
Vishal Mega Mart reported an 18.7% revenue growth in Q1 FY27, with a strong 10% same-store sales growth, indicating resilience amid a challenging environment…
Urban Company Ltd (Q1 FY27)
India Consumer Services business shows strong and accelerating growth, with 29% year-on-year growth reported in a recent quarter, improving from lower…
Spencers Retail Ltd (Q1 FY27)
Consolidated revenue grew 13% YoY to Rs. Key concall takeaways from Spencers Retail Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Eternal Ltd vs Avenue Super.vs Trent Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Medplus Health Services Ltd Q1 FY27 results?

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 37.6 with a market cap of ₹7,925 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medplus Health Services Ltd planning capital expenditure?

The company had approved capex plans including INR40 crores for a food park and oil extraction unit and another for a wellness services facility.

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.